← Leaderboards
Matthew Lordo
Ohio State University
$193,322
Attributed
$193,322
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$193,322 · 1
By mechanism
F30$193,322 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Louis M Mansky$15,115,622
- Michael A Caligiuri$65,062,344
- David P Carbone$20,647,321
- Roger Ratcliff$9,919,804
- Amal O Amer$14,350,541
Others in their field
Other Rising Stars on “Disease Progression”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Angee Greer · Ppd Development Lp$82,531,927
- Mari Ostendorf · University Of Washington$51,931,230
- Sabrina Paganoni · Massachusetts General Hospital$25,017,559
- Suma Babu · Massachusetts General Hospital$25,017,559
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
Research focus
Disease ProgressionAdoptive TransferAcute Myeloid Leukemia CellAcute Myelocytic LeukemiaAreaAryl Hydrocarbon ReceptorAryl Hydrocarbon Receptor LigandAffectBiologyAgonistCell LineCell LineageCell MaturationCell PhysiologyCell TypeClinical ResearchCoculture TechniquesConditional KnockoutCytokineCytotoxicDefectCancer CellDetectionFamily
Grant awards (4)
Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid Leukemia$54,538
F30 · FY2025 · CA · contact PI
Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid Leukemia$53,974
F30 · FY2024 · CA · contact PI
Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid Leukemia$42,876
F30 · FY2023 · CA · contact PI
Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid Leukemia$41,934
F30 · FY2022 · CA · contact PI